On Friday, Skye Bioscience Inc (NASDAQ: SKYE) was 14.17% up from the session before settling in for the closing price of $3.6. A 52-week range for SKYE has been $1.14 – $5.96.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 42.99%. When this article was written, the company’s average yearly earnings per share was at -86.69%. With a float of $18.10 million, this company’s outstanding shares have now reached $30.99 million.
Skye Bioscience Inc (SKYE) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Skye Bioscience Inc stocks. The insider ownership of Skye Bioscience Inc is 41.59%, while institutional ownership is 27.39%. The most recent insider transaction that took place on Aug 22 ’25, was worth 582,936. In this transaction Director of this company sold 170,449 shares at a rate of $3.42, taking the stock ownership to the 57,493 shares. Before that another transaction happened on Aug 21 ’25, when Company’s Director sold 60,956 for $3.57, making the entire transaction worth $217,613. This insider now owns 63,963 shares in total.
Skye Bioscience Inc (SKYE) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.1 earnings per share (EPS) during the time that was better than consensus figure (set at -0.25) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around -86.69% per share during the next fiscal year.
Skye Bioscience Inc (NASDAQ: SKYE) Trading Performance Indicators
You can see what Skye Bioscience Inc (SKYE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.07, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.31 in one year’s time.
Technical Analysis of Skye Bioscience Inc (SKYE)
The latest stats from [Skye Bioscience Inc, SKYE] show that its last 5-days average volume of 0.44 million was inferior to 0.62 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.04%.
During the past 100 days, Skye Bioscience Inc’s (SKYE) raw stochastic average was set at 59.71%, which indicates a significant decrease from 63.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.71, while its 200-day Moving Average is $2.87. Now, the first resistance to watch is $4.34. This is followed by the second major resistance level at $4.58. The third major resistance level sits at $5.00. If the price goes on to break the first support level at $3.69, it is likely to go to the next support level at $3.27. The third support level lies at $3.04 if the price breaches the second support level.
Skye Bioscience Inc (NASDAQ: SKYE) Key Stats
There are 30,988K outstanding shares of the company, which has a market capitalization of 127.36 million. As of now, sales total 0 K while income totals -26,570 K. Its latest quarter income was 0 K while its last quarter net income were -17,620 K.
